Acción VELO VELOXIS PHARMACEUTICALS A/S
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Veloxis Pharmaceuticals A/S

Acciones

VELO

DK0060048148

Diferido Nasdaq Copenhagen
Otros sitios de cotización
 		Varia. Cinco días. Varia. 1 de enero.
- DKK -.--% Gráfico intradía de Veloxis Pharmaceuticals A/S -.--% -0,50 %
2022 Veloxis Pharmaceuticals anuncia la dosificación del primer paciente por parte de su socio Xenikos en el estudio global de fase 3 que evalúa T-Guard(R) en pacientes con enfermedad de injerto contra huésped aguda refractaria a los esteroides (SR-aGVHD) CI
2019 Transcript : Asahi Kasei Pharma Denmark A/S, Veloxis Pharmaceuticals A/S - M&A Call

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)
Scandion Oncology A/S : appoints Johnny Stilou as new CFO
Veloxis Pharmaceuticals, Inc entered into a global license agreement to acquire Worldwide Rights to FR104 from OSE Immunotherapeutics SA.
Veloxis Pharmaceuticals A/S : Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020
Veloxis Pharmaceuticals A/S Announces Board Appointments
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from OMX Nordic All-Share Index
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
Veloxis Pharmaceuticals A/S : Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S
Veloxis Pharmaceuticals A/S : - Notice to Convene Extraordinary General Meeting
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications
Veloxis Pharmaceuticals A/S : Notice to Convene Extraordinary General Meeting
Veloxis Pharmaceuticals A/S : Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S: Major Shareholder Notifications
Veloxis Pharmaceuticals A/S : Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
Veloxis Pharmaceuticals A/S : - Reporting of Managers and Closely Associated Persons Transactions in Veloxis-Shares and Financial Instruments Linked Hereto
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción VELO
  4. Noticias Veloxis Pharmaceuticals A/S
  5. Otros idiomas